{"nct_id":"NCT03444753","title":"An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed","status":"TERMINATED","status_verified_date":"2022-05","start_date":"2018-04-05","start_date_type":"ACTUAL","primary_completion_date":"2022-02-14","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}